Spasticity Epidemiology Forecast 2025-2034

Spasticity Epidemiology Forecast Report Coverage

Expert Market Research's “Spasticity Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of spasticity. It projects the future incidence and prevalence rates of spasticity across various populations. The study covers age and type as major determinants of the spasticity-affected population. The report highlights patterns in the prevalence of spasticity over time and projects future trends based on multiple variables.

Spasticity: Disease Overview

Spasticity refers to a form of hypertonia characterized by abnormal muscle tightness or stiffness. The condition can make it difficult to walk, speak, move, and perform other daily activities. Spasticity is caused by the disruption in communication between the spinal cord and brain and the muscles. It is considered a symptom of neurological conditions like stroke, cerebral palsy, spinal cord injury, multiple sclerosis, and traumatic brain injury, among others.

Spasticity: Treatment Overview

Oral medications like benzodiazepines, dantrolene sodium, tizanidine, imidazolines, baclofen, and gabapentin can aid in relieving symptoms of spasticity. Intrathecal medications such as phenol and baclofen, which are released into the cerebrospinal fluid with the help of a surgically placed pump, are also used as a treatment option. Additionally, occupational and physical therapy are also recommended to help improve mobility, muscle flexibility, and coordination.

Epidemiology

The spasticity epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for spasticity by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for spasticity and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Around 12 million individuals suffer from spasticity, with spasms, continuous muscle stiffness, and involuntary contractions being the common symptoms.
• Studies show that spasticity is estimated to affect about 35% of people who experienced a stroke, over 90% of individuals with cerebral palsy, nearly 50% of the traumatic brain injury-affected population, 37 to 78% of multiple sclerosis patients, and 40% of people who have spinal cord injury.
• As per an article published in the Journal of Stroke and Cerebrovascular Diseases (2020), the onset of spasticity is highly variable, with prevalence ranging from 4 to 43% and the incidence of disability estimated to be 2 to 13%.
• The pooled incidence of spasticity post-stroke is reported to be 25.3%, according to a systematic review and meta-analysis published in the Frontiers in Neurology (2021).

Country-wise Spasticity Epidemiology

The spasticity epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of spasticity varies significantly between countries due to differences in the prevalence of underlying conditions such as stroke, multiple sclerosis, or cerebral palsy, advancements in healthcare infrastructure, and access to treatment, among others. In the United States, nearly 795,000 individuals are affected by stroke, out of which 25 to 43% of people are likely to experience spasticity in their first post-stroke year.

Country Specific Stats:

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of spasticity based on several factors.
• Spasticity Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of spasticity are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of spasticity epidemiology in the 8 major markets?
• What will be the total number of patients with spasticity across the 8 major markets during the forecast period?
• What was the country-wise prevalence of spasticity in the 8 major markets in the historical period?
• Which country will have the highest number of spasticity patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of spasticity during the forecast period of 2025-2034?
• What are the currently available treatments for spasticity?
• What are the disease risks, signs, symptoms, and unmet needs of spasticity?

Related Reports

Cerebral Palsy Epidemiology Forecast

Ischemic Stroke Market